Nuclear medicine technology. Progress report, quarter ending March 31, 1980

PDF Version Also Available for Download.

Description

The successful detection of experimentally produced myocardial infarctions in rats and dogs using /sup 123m/Te-9-telluraheptadecanoic acid (9-(/sup 123m/Te)-THDA) is described. Preferential localization of radioactivity in normal myocardial tissue of rats that had experimentally produced infarctions was also demonstrated by tissue distribution studies following injection of 9-(/sup 123m/Te)-THDA. The effects of chain length on the myocardial uptake of /sup 75/Se-labeled long-chain fatty acids was also studied further. Selenium-75-labeled 13-selenaheneicosonic acid (H/sub 3/C-(CH/sub 2/)/sub 7/-/sup 75/Se-(CH/sub 2/)/sub 11/-COOH, 13-(/sup 75/Se)-SHCA) shows the highest heart uptake in rats of the agents studied. These results indicate that myocardial imaging may be possible with 13-(/sup … continued below

Physical Description

25 pages

Creation Information

Knapp, F. F. Jr. October 1, 1980.

Context

This report is part of the collection entitled: Office of Scientific & Technical Information Technical Reports and was provided by the UNT Libraries Government Documents Department to the UNT Digital Library, a digital repository hosted by the UNT Libraries. More information about this report can be viewed below.

Who

People and organizations associated with either the creation of this report or its content.

Publisher

Provided By

UNT Libraries Government Documents Department

Serving as both a federal and a state depository library, the UNT Libraries Government Documents Department maintains millions of items in a variety of formats. The department is a member of the FDLP Content Partnerships Program and an Affiliated Archive of the National Archives.

Contact Us

What

Descriptive information to help identify this report. Follow the links below to find similar items on the Digital Library.

Description

The successful detection of experimentally produced myocardial infarctions in rats and dogs using /sup 123m/Te-9-telluraheptadecanoic acid (9-(/sup 123m/Te)-THDA) is described. Preferential localization of radioactivity in normal myocardial tissue of rats that had experimentally produced infarctions was also demonstrated by tissue distribution studies following injection of 9-(/sup 123m/Te)-THDA. The effects of chain length on the myocardial uptake of /sup 75/Se-labeled long-chain fatty acids was also studied further. Selenium-75-labeled 13-selenaheneicosonic acid (H/sub 3/C-(CH/sub 2/)/sub 7/-/sup 75/Se-(CH/sub 2/)/sub 11/-COOH, 13-(/sup 75/Se)-SHCA) shows the highest heart uptake in rats of the agents studied. These results indicate that myocardial imaging may be possible with 13-(/sup 75/Se)-SHCA and also suggest that potential positron emission tomography of the myocardium with the /sup 73/Se-labeled agent should be explored. The results of continuing studies with /sup 11/C and /sup 195m/Pt-labeled agents are also described. A variety of /sup 11/C-labeled amino acids were prepared and tested as pancreas and tumor localizing agents in a Medical Cooperative Program with the Oak Ridge Associated Universities. The microscale synthesis of /sup 195m/Pt-labeled cis-dichloro-trans-dihydroxy-bis-(isopropylamine)platinum(IV) (/sup 195m/Pt-CHIP) was developed further and preliminary tissue distribution studies with this important second-generation antitumor drug were completed in rats. Platinum-195m-labeled cis-dichlorodiammineplatinum(II) (/sup 195m/Pt-cis-DDP) was supplied for testing to a number of Medical Cooperative Programs. Studies of arsenic trioxide (As/sub 2/O/sub 3/) toxicity for human cells in the diffusion chamber assay system have continued. Further investigation of this arsenic-induced cytotoxicity has demonstrated a linear dose-response relationship and a difference in the permanence of the growth inhibitory effect using different doses.

Physical Description

25 pages

Notes

NTIS, PC A02/MF A01.

Subjects

Keywords

STI Subject Categories

Language

Item Type

Identifier

Unique identifying numbers for this report in the Digital Library or other systems.

Collections

This report is part of the following collection of related materials.

Office of Scientific & Technical Information Technical Reports

Reports, articles and other documents harvested from the Office of Scientific and Technical Information.

Office of Scientific and Technical Information (OSTI) is the Department of Energy (DOE) office that collects, preserves, and disseminates DOE-sponsored research and development (R&D) results that are the outcomes of R&D projects or other funded activities at DOE labs and facilities nationwide and grantees at universities and other institutions.

What responsibilities do I have when using this report?

When

Dates and time periods associated with this report.

Creation Date

  • October 1, 1980

Added to The UNT Digital Library

  • July 3, 2018, 8:14 a.m.

Description Last Updated

  • Jan. 20, 2021, 10:16 p.m.

Usage Statistics

When was this report last used?

Yesterday: 0
Past 30 days: 0
Total Uses: 5

Interact With This Report

Here are some suggestions for what to do next.

Start Reading

PDF Version Also Available for Download.

International Image Interoperability Framework

IIF Logo

We support the IIIF Presentation API

Knapp, F. F. Jr. Nuclear medicine technology. Progress report, quarter ending March 31, 1980, report, October 1, 1980; Tennessee. (https://digital.library.unt.edu/ark:/67531/metadc1199560/: accessed July 16, 2024), University of North Texas Libraries, UNT Digital Library, https://digital.library.unt.edu; crediting UNT Libraries Government Documents Department.

Back to Top of Screen